Literature DB >> 861759

Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease.

K G Iloyd, L Shemen, O Hornykiewicz.   

Abstract

The regional distribution and properties of the sodium-independent "specific" binding of [3H]GABA to membranes prepared from human brains (control and Parkinsonian patients) have been investigated. The affinity of [3H]GABA for the binding site was similar for human cerebellar cortex (Kd = 3.4 x 10(-7) M) and whole rat brain brain (Kd = 5.1 x 10(-7) M) and was inhibited by bicuculline (ID50 = 2.2 X 10(-5) M). In the normal human brain the cerebellar cortex demonstrated the highest number of binding sites, in accordance with the large number of GABA interneurons in this structure. The hippocampus also displayed a high capacity to bind [3H]GABA, whereas cerebral cortical areas showed a lesser capacity. [3H]GABA binding was similar in many regions of the basal ganglia (amygdala, putamen, caudate or accumbens) but was lower than that for the cortical regions. The binding of [3H]GABA to membranes from the substantia nigra, thalamus and internal or external pallidum was lower than for the above regions. Subcortical white matter did not exhibit specific binding for [3H]GABA. In membranes prepared from Parkinsonian patients [3H]GABA binding was greatly decreased in the substantia nigra, but not in other brain areas examined. From this observation it was concluded that there are [3H]-brain areas examined. From this observation it was concluded that there are [3H]-GABA binding sites on the cell bodies (or dendrites) of the nigral dopamine neurons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861759     DOI: 10.1016/0006-8993(77)90540-6

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

Review 1.  Vertebrate GABA receptors.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1978-06       Impact factor: 3.996

Review 2.  Biochemical dissection of the gamma-aminobutyrate synapse.

Authors:  A J Turner; S R Whittle
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

3.  Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia nigra.

Authors:  J Arnt; J Scheel-Krüger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  Ligand-binding studies on GABA receptors--relation to physiology and behavior.

Authors:  F V DeFeudis
Journal:  Neurochem Res       Date:  1984-03       Impact factor: 3.996

5.  Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat.

Authors:  D M Coward
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

6.  Distribution and characterization of the GABA receptors in the CNS of ataxic mutant mouse.

Authors:  T Yamaguchi; K Hayashi; H Murakami; S Maruyama; M Yamaguchi
Journal:  Neurochem Res       Date:  1984-04       Impact factor: 3.996

Review 7.  Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.

Authors:  A V Christensen; O Svendsen; P Krogsgaard-Larsen
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

8.  CSF and plasma GABA levels in Parkinson's disease.

Authors:  R J Abbott; I F Pye; S R Nahorski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

Review 9.  The hypothalamus in Parkinson disease.

Authors:  R Sandyk; R P Iacono; C R Bamford
Journal:  Ital J Neurol Sci       Date:  1987-06

10.  Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam.

Authors:  D M Coward
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.